| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |